Johnson & Johnson is due to issue a Continuation Decision by Q3 2018.
Geron will receive a $65 or $135 million milestone payment when a continuation decision happens.
Historical analysis of JNJ slides bode well for Geron and imetelstat.
It is reasonable to conclude that the protocol-specified primary analysis for IMbark is now in progress.
READ FULL ARTICLE HERE